Filing metadata

Accession number
0001193125-26-022845
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Jan 26, 2026
Reporting period
Jan 22, 2026
Description
Insider transaction

Explore SEC Filings Hub